Srd5a3 - steroid 5 alpha-reductase 3 Gene
Also Known as S5AR 3; RGD1308828
生物種: Rattus norvegicus
Summary
Predicted to enable 3-oxo-5-alpha-steroid 4-dehydrogenase activity and oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor. Predicted to be involved in dolichol biosynthetic process; dolichol-linked oligosaccharide biosynthetic process; and polyprenol catabolic process. Predicted to be located in endoplasmic reticulum membrane. Predicted to be integral component of membrane. Predicted to be active in endoplasmic reticulum. Human ortholog(s) of this gene implicated in Kahrizi syndrome and congenital disorder of glycosylation Iq. Orthologous to human SRD5A3 (steroid 5 alpha-reductase 3). [provided by Alliance of Genome Resources, Apr 2022]
Srd5a3 Products (2)
| mRNA | Protein | Name |
|---|---|---|
| NM_001013990.1 | NP_001014012.1 | polyprenol reductase isoform 1 |
| NM_001401433.1 | NP_001388362.1 | polyprenol reductase isoform 2 |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
polyprenol reductase |
|
|
Related Agents
- Pre-clinical Phase
Pre-clinical Phase
| 製品番号 | 製品名 |
製品効果
|
純度 |
Rare Diseases
|
|---|---|---|---|---|
| HY-RS21945 | Srd5a3 Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-W010076 | Methyl 2,4-dihydroxybenzoate | Inhibitor | 99.57% | Unkown |
| HY-163938A | PROTAC erf3a Degrader-2 | / | Unkown | |
| HY-RS13756 | SRD5A3 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
Compound Screening Libraries
Virtual Screening
Customize Your Library
Drug Screening Service